Privia Health Group, Inc. Cost, Depreciation
Privia Health Group, Inc. (PRVA) reported Cost, Depreciation of $700.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-27.
Financial Statements › Expense Statement
us-gaap:CostOfGoodsAndServicesSoldDepreciation · last filed 2026-02-27
- Privia Health Group, Inc. cost, depreciation for fiscal 2025 was $700.00K, a 36.36% decline from fiscal 2024.
- Privia Health Group, Inc. cost, depreciation for fiscal 2024 was $1.10M, a 8.33% decline from fiscal 2023.
- Privia Health Group, Inc. cost, depreciation for fiscal 2023 was $1.20M, a 0.00% change from fiscal 2022.
- Privia Health Group, Inc. cost, depreciation for fiscal 2022 was $1.20M, a 0.00% change from fiscal 2021.
| Period end | Cost, Depreciation 12 month |
|---|---|
| 2025-12-31 | $700.00K 10-K · filed 2026-02-27 |
| 2024-12-31 | $1.10M 10-K · filed 2026-02-27 |
| 2023-12-31 | $1.20M 10-K · filed 2026-02-27 |
| 2022-12-31 | $1.20M 10-K · filed 2025-02-27 |
| 2021-12-31 | $1.20M 10-K · filed 2024-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |